Adenosine shortage — DE supply status & alternatives

Adenosine

ATC C01EB10

🇦🇺 AUST R 285957 · Baxter Healthcare Pty Ltd

Anticipated · Australia

AdrekarViatris Adenoscan

Anticipated · 🇦🇺 Australia & also short in🇩🇪 DE🇺🇸 US

Anticipated shortage

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Sept 2026

Sponsor est. via TGA

Product attributes reference data we hold

Active ingredient (INN)	Adenosine
Brand names	Adrekar, Viatris, Adenoscan
ATC level 5	C01EB10
ATC level 4	C01EB
Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Controlled substance	No
Marketing-authorisation holders	Baxter Healthcare Pty Ltd, BAXTER HEALTHCARE LIMITED, FRESENIUS KABI LIMITED, HIKMA FARMACEUTICA (PORTUGAL) SA +6 more
Registrations on file	17
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

8 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Zhejiang Hisun Pharmaceutical CO LTDPharma-Waldhof GMBHWockhardt LTDEuticals SPAEmcure Pharmaceuticals LTDJiangsu Synthgene Biotechnology CO LTD+2 more

Manufacturing countries: China, India · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

Adenosine

Pharmakon Pharmaceuticals, Inc. · Apr 2016

Class IIdetails ↗

🇺🇸

Adenosine

Central Admixture Pharmacy Services, Inc. · May 2014

Class Idetails ↗

🇺🇸

Adenosine

Main Street Family Pharmacy, LLC · May 2013

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders17 registrations · 10 MA holders

Product	Strength	Form	Market	MA holder	Status
ADSINE adenosine	6 mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
ADENOSINE 3 MG/ML SOLUTION FOR INJECTION	3 MG	injection	🇬🇧 GB	BAXTER HEALTHCARE LIMITED	Active
ADENOSINE 30 MG/10 ML, SOLUTION FOR INFUSION	30 MG	solution	🇬🇧 GB	BAXTER HEALTHCARE LIMITED	Active
ADENOSINE 3 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE	3 MG	injection	🇬🇧 GB	FRESENIUS KABI LIMITED	Active
ADENOSINE 6 MG/2 ML SOLUTION FOR INJECTION	6 MG	injection	🇬🇧 GB	HIKMA FARMACEUTICA (PORTUGAL) SA	Active
ADENOSINE 3MG/ML SOLUTION FOR INJECTION	3MG	injection	🇬🇧 GB	FOCUS PHARMACEUTICALS LIMITED	Active
ADENOSINE 30MG/10ML SOLUTION FOR INFUSION	30MG	solution	🇬🇧 GB	FOCUS PHARMACEUTICALS LIMITED	Active
Orthoplex Adenosine	—	—	🇦🇺 AU	Bio Concepts Pty Ltd	Active
ADENOCOR Adenosine	6mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
ADENOSCAN adenosine	30mg	—	🇦🇺 AU	Sanofi-Aventis Australia Pty Ltd	Active
Viatris	6 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
ADENOVIEW adenosine	60 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
ADENOVIEW adenosine	90 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
ADENOVIEW adenosine	30 mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
Baxter	30 mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active

+2 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.